A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)

Name: A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)
License: Public Domain

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

covid-19

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 325158
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.